Investor Presentation Q1 2023

105 Investor presentation First three months of 2023 GLP-1 market share and market growth 100% 80% 60% 40% 20% GLP-1 market growth and Novo Nordisk market share 0% Feb 2020 DKK billion 80% 76% 60% 58% 28 65% 46% 40% 20% 60% GLP-1 market size and growth ~46% 3 41 10 -58% 65% 0% Feb 2023 Feb 2022 Novo Nordisk AZ Others Feb 2023 NN market share -Market growth (Right Axis) NN share of growth Novo Nordisk Competitors NN growth (Right Axis) Source: IQVIA, Feb 2023, Value MAT, all countries; NN: Novo Nordisk; AZ: Astra Zeneca Novo NordiskⓇ

View entire presentation